晨间信号Morning Signal
《科学》 第391卷 第6785期 · 2026年2月5日 · 中文解读

基孔肯雅疫苗副作用引发担忧

Side effects dim hopes for first chikungunya vaccine · Vaishnavi Chandrashekhar
约 11 分钟News在小程序里点播,20 到 60 分钟做好
这篇讲什么
本文报道了首个基孔肯雅疫苗IXCHIQ在留尼汪岛疫情中因老年人出现严重副作用而暂停使用,以及新疫苗Vimkunya可能更安全的情况。
原文开头
Vaccination of the elderly was suspended during an outbreak on Réunion last year. A new vaccine may be safer VAISHNAVI CHANDRASHEKHAR, in Saint-Denis, Réunion In March 2025, a chikungunya epidemic was sweeping this French territory in the western Indian Ocean, and 66-year-old company manager Joël Rivière was getting increasingly worried. The widespread viral disease is rarely deadly, but it can cause high fever and crippling joint pains. His doctor told Rivière a vaccine existed—but it turned out to have drawbacks. First, Rivière learned the shot would cost €200, which was too expensive for him. …
摘自《科学》(Science)第391卷 第6785期 · 2026年2月5日,Vaishnavi Chandrashekhar。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。
晨间信号小程序码
微信扫码,在小程序里听完整版
不用登录先听一篇 · 或在微信搜索小程序 晨间信号
同期其他文章